- Common Postmortem Computed Tomography Findings Following Atraumatic Death: Differentiation between Normal Postmortem Changes and Pathologic Lesions
-
Ishida M, Gonoi W, Okuma H, Shirota G, Shintani Y, Abe H, Takazawa Y, Fukayama M, Ohtomo K
- KMID: 2155553
- Korean J Radiol.
- 2015 Aug;16(4):798-809.
- doi: 10.3348/kjr.2015.16.4.798
Computed tomography (CT) is widely used in postmortem investigations as an adjunct to the traditional autopsy in forensic medicine. To date, several studies have described postmortem CT findings as being... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk of lingual nerve injuries in removal of mandibular third molars: a retrospective case-control study
-
Tojyo I, Nakanishi , Shintani Y, Okamoto K, Hiraishi Y, Fujita S
- KMID: 2468987
- Maxillofac Plast Reconstr Surg.
- 2019 ;41(1):40.
- doi: 10.1186/s40902-019-0222-4
BACKGROUND: Through the analysis of clinical data, we attempted to investigate the etiology and determine the risk of severe iatrogenic lingual nerve injuries in the removal of the mandibular third... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of duration from lingual nerve injury to undergoing microneurosurgery on improving sensory and taste functions: retrospective study
-
Nakanishi , Yamamoto Y, Tanioka K, Shintani Y, Tojyo I, Fujita S
- KMID: 2469008
- Maxillofac Plast Reconstr Surg.
- 2019 ;41(1):61.
- doi: 10.1186/s40902-019-0244-y
BACKGROUND: The prognosis of recovery following microneurosurgery for injured lingual nerves varies among individual cases. This study aimed to investigate if recovery ratios of sensory and taste functions are improved... -
- CITED
-
- Close
- SHARE
-
- Close
- PD-L1 expression correlated with p53 expression in oral squamous cell carcinoma
-
Tojyo I, Shintani Y, Nakanishi , Okamoto K, Hiraishi Y, Fujita S, Enaka M, Sato F, Muragaki Y
- KMID: 2469003
- Maxillofac Plast Reconstr Surg.
- 2019 ;41(1):56.
- doi: 10.1186/s40902-019-0239-8
BACKGROUND: Programmed cell death ligand 1 (PD-L1) is an immune checkpoint molecule that attenuates the immune response. PD-L1 contributes to failed antitumor immunity; thereby, blockade of PD-L1 with monoclonal antibody... -
- CITED
-
- Close
- SHARE
-
- Close
